Aeries Technology (NasdaqCM:AERT) Q3 2026 Earnings call February 09, 2026 08:00 AM ET Company ParticipantsAjay Khare - CEODaniel Webb - CFOOperatorToday, and welcome to Aeries Technology third quarter and fiscal year 2026 earnings call. Joining us today on the call are Aeries Chief Executive Officer Ajay Khare and Chief Financial Officer Daniel Webb. The call will review the results for the quarter ended December 31st, 2025, and outline strategic priorities that are shaping the next stage of our growth. Bef ...

Edgewell Personal Care Company (NYSE:EPC) Q1 2026 Earnings call February 09, 2026 08:00 AM ET Company ParticipantsChris Gough - VP of Investor RelationsFran Weissman - CFOOlivia Tong - Managing DirectorRod Little - President and CEOConference Call ParticipantsChris Carey - Equity Analyst and Head of Consumer Staples ResearchNik Modi - Consumer Staples Equity Research AnalystPeter Grom - Equity Research AnalystSusan Anderson - Managing Director and Senior AnalystOperatorPlease note, this event is being recor ...

Becton, Dickinson and Company (NYSE:BDX) Q1 2026 Earnings call February 09, 2026 08:00 AM ET Company ParticipantsJayson Bedford - Managing Director in Equity ResearchPatrick Wood - Managing Director in Equity ResearchRick Wise - Managing DirectorShawn Bevec - Senior Vice President of Investor RelationsTom Polen - Chairman, CEO and PresidentTravis Steed - Managing Director in Equity ResearchVitor Roque - SVP and Interim CFOConference Call ParticipantsJoanne Wuensch - Managing Director and Senior Equity Resea ...

Financial Data and Key Metrics Changes - Revenue for Q3 FY 2026 was $17.5 million, slightly down from $17.6 million in the prior year period [8] - Adjusted EBITDA improved significantly to $2.5 million from a loss of $2 million in Q3 FY 2025, marking a turnaround [8][9] - Adjusted EBITDA margin was approximately 14.1%, a notable improvement from the previous year's negative margin [2][8] - Operating cash flow was positive for the third consecutive quarter at $2.4 million, indicating strong cash generation [9] Business Line Data and Key Metrics Changes - The company reported stable revenue across its business lines, with improved margins driven by automation and efficiency initiatives [2][3] - Continued momentum in AI-led transformation and GCC practices contributed to operational improvements [3][4] - Multi-year engagements with clients are expected to enhance revenue visibility and profitability in the future [4][5] Market Data and Key Metrics Changes - The company is seeing strong engagement across the Private Equity ecosystem and various industry sectors, reinforcing its market position [4] - The nearshore presence in Mexico is scaling, with recent engagements further strengthening long-term positioning [4] Company Strategy and Development Direction - The company is focused on creating a predictable and efficient operating model, with an emphasis on automation and AI capabilities [2][3] - Strategic relationships with clients are maturing into multi-year engagements, highlighting the durability of client relations [5] - The outlook for fiscal 2027 anticipates revenue in the range of $80 million to $84 million, supported by signed contracts and active program ramp-ups [7][10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the revenue and profitability profile for fiscal 2027, citing strong visibility from multi-year contracts [6][10] - The company expects further contributions to revenue and profits as programs progress towards steady state [10] - The balance sheet remains healthy, positioning the company well for continued growth and improved profitability [11] Other Important Information - The company achieved its third Great Place to Work certification, reflecting strong talent retention and engagement [5] - Adjusted EBITDA guidance for the full fiscal year 2026 has been increased to a range of $7 million to $8 million, up from the previous guidance of $6 million to $8 million [9] Q&A Session Summary - No specific questions or answers were provided in the content, thus this section is not applicable.

Curbline Properties (NYSE:CURB) Q4 2025 Earnings call February 09, 2026 08:00 AM ET Company ParticipantsConor Fennerty - CFODavid Lukes - CEOHong Zhang - VP, Sell Side covering REITsRonald Kamdem - Managing Director, Head of US REITs and CRE ResearchStephanie Ruys de Perez - Vice President of Capital MarketsNone - Company RepresentativeConference Call ParticipantsAlexander Goldfarb - Senior REIT Analyst, Managing DirectorCraig Mailman - Director, Equity Research AnalystFloris van Dijkum - Managing Director, ...

Edgewell Personal Care Company (NYSE:EPC) Q1 2026 Earnings call February 09, 2026 08:00 AM ET Company ParticipantsChris Gough - VP of Investor RelationsFran Weissman - CFOOlivia Tong - Managing DirectorRod Little - President and CEOConference Call ParticipantsChris Carey - Equity Analyst and Head of Consumer Staples ResearchNik Modi - Consumer Staples Equity Research AnalystPeter Grom - Equity Research AnalystSusan Anderson - Managing Director and Senior AnalystOperatorPlease note, this event is being recor ...

Financial Data and Key Metrics Changes - Total revenue for Q1 2026 was $5.3 billion, reflecting a 0.4% increase year-on-year, with new BD growing by 2.5% [4][15] - Adjusted gross margin was 53.4%, down 140 basis points from the previous year, primarily due to tariffs [17] - Adjusted EPS was $2.91, a decrease of 15.2% year-on-year, driven mainly by the impact of tariffs [17][20] - Free cash flow for the quarter was $548 million, with a conversion rate of 66%, up from 59% in the prior year [18] Business Line Data and Key Metrics Changes - Medical Essentials saw mixed performance, with expected order timing dynamics affecting MDS, but continued share gains in the US vascular access management portfolio [15] - Connected Care delivered mid-single-digit growth, led by APM with high single-digit growth [15] - Biopharma Systems grew low single digits, with double-digit growth in biologics, particularly GLP-1s, offset by lower vaccine demand [16] - Interventional business experienced solid mid-single-digit growth, driven by high single-digit growth in UCC and double-digit growth in PureWick [16] Market Data and Key Metrics Changes - Growth was pressured by market dynamics in China, particularly in the life sciences segment, which declined due to headwinds in US point-of-care and difficult comparisons from the prior year [17] - The company expects the value-based procurement (VBP) in China to impact 80% of its portfolio by the end of 2026, with a projected headwind of about 250 basis points for the full year [36] Company Strategy and Development Direction - The company is focused on a balanced capital allocation strategy, prioritizing share repurchases and tuck-in M&A in high-growth markets [6][73] - The transformation into a pure-play med tech company is supported by divesting non-core assets and enhancing its portfolio through strategic acquisitions [7] - The company identified three key trends shaping healthcare: the rise of smart devices, the shift towards lower-cost care settings, and the growth in technologies addressing chronic diseases [7] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the trajectory of the business, maintaining a prudent approach to guidance for fiscal 2026, expecting low single-digit revenue growth [20] - The company anticipates that pricing dynamics will improve as VBP in China abates, potentially leading to positive pricing in the future [85] - Management highlighted strong execution in commercial initiatives and a robust innovation pipeline, which are expected to drive future growth [9][68] Other Important Information - The company completed a significant transaction with Waters, receiving a $4 billion cash distribution, with plans to allocate $2 billion for share repurchases and $2 billion for debt paydown [6][19] - The company has reduced its manufacturing network by nearly half, which is expected to lower costs and improve operational efficiency [13][50] Q&A Session Summary Question: Guidance for Q2 revenue and EPS - Management confirmed that Q2 guidance reflects modest timing benefits and remains aligned with Q1 performance, with no fundamental changes expected [23][44] Question: Structural changes affecting mid-single-digit growth - Management reassured that the fundamentals across the majority of the portfolio remain strong, with continued investment in high-growth areas [28] Question: Impact of Alaris and vaccines in China - Management indicated that Alaris is expected to improve in 2027, while vaccine impacts are anticipated to lessen over time [36][71] Question: Pricing environment and innovation impact - Management noted a stable pricing environment with slight positive trends expected, particularly as new product innovations are introduced [84][85]

Aeries Technology (NasdaqCM:AERT) Q3 2026 Earnings call February 09, 2026 08:00 AM ET Speaker2Today, and welcome to Aeries Technology third quarter and fiscal year 2026 earnings call. Joining us today on the call are Aeries Chief Executive Officer Ajay Khare and Chief Financial Officer Daniel Webb. The call will review the results for the quarter ended December 31st, 2025, and outline strategic priorities that are shaping the next stage of our growth. Before we begin, please note that today's discussion con ...

Financial Data and Key Metrics Changes - In Q4 2025, NOI increased by 16% sequentially and almost 60% year-over-year, driven by acquisitions and organic growth [12] - The lease rate remained unchanged at 96.7%, with occupancy up 20 basis points [13] - Full-year same-property NOI growth was 3.3%, with Q4 growth at 1.5% despite a 50 basis point headwind from uncollectible revenue [13][14] - The company forecasts FFO guidance for 2026 in the range of $1.17 to $1.21 per share, representing a 12% year-over-year growth [14][15] Business Line Data and Key Metrics Changes - The company signed over 400,000 sq ft of new leases and renewals in 2025, with new lease spreads averaging 20% and renewal spreads just under 10% [5] - Capital expenditures were just 7% of NOI for the full year, indicating high capital efficiency [5][14] Market Data and Key Metrics Changes - The total U.S. market for convenience retail assets is 950 million sq ft, significantly larger than the company's current portfolio of almost 5 million sq ft [6] - The company has built a significant network of relationships with sellers and brokers, which is crucial for growth in a fragmented market [7] Company Strategy and Development Direction - The company focuses on acquiring top-tier convenience retail assets, leveraging a first-mover advantage in the public market [4] - The strategy emphasizes simple, flexible buildings that align with consumer behavior, catering to daily errands rather than destination shopping [9] - The company aims for double-digit cash flow growth, supported by a strong balance sheet and operational efficiency [11] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the growth opportunities in the convenience sector, citing a significant addressable investment market [5] - The company anticipates continued strong demand for its properties, with expectations for same-property NOI growth of 3% in 2026 [15][27] - Management noted that the business plan has been accelerated due to better-than-expected operational performance and a strong acquisition pipeline [78] Other Important Information - The company ended the year with a leverage ratio of less than 20%, providing substantial liquidity for future acquisitions [19] - The company has raised a total of $600 million in debt capital since its formation, with a weighted average interest rate of approximately 5% [18] Q&A Session Summary Question: Can you talk about the acquisition pipeline and cap rates? - Management indicated that cap rates have remained just north of 6%, with a range from mid-5s to high 6s depending on various factors [23][24] Question: Can you elaborate on same-store NOI and leasing spreads? - Management noted that leasing spreads are expected to return to low 20s, and same-property NOI guidance for 2026 is a wide range of 2%-4% [26][27][30] Question: Are there any operating synergies from having multiple properties in single markets? - Management acknowledged some operational synergies but emphasized that the high recovery rate of the asset class minimizes their impact on overall performance [36][37] Question: What is the thought process on incremental equity issuance versus building out the debt ladder? - Management highlighted a broad range of options for capital sources, emphasizing the importance of maintaining flexibility in funding strategies [54][55] Question: Can you discuss the recent disposition and future asset management activities? - Management confirmed that there are no planned dispositions for 2026, with the recent sale being a small, opportunistic decision [66][68]

Edgewell Personal Care Company (NYSE:EPC) Q1 2026 Earnings call February 09, 2026 08:00 AM ET Speaker5Please note, this event is being recorded. I would now like to turn the conference over to Chris Goff, Vice President, Investor Relations. Please go ahead.Speaker1Good morning, everyone, and thank you for joining us this morning for Edgewell's first quarter fiscal year 2026 earnings call. With me this morning are Rod Little, our President and Chief Executive Officer, and Fran Weissman, our Chief Financial O ...